Fesik SW - Search Results

1

Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1B.

Liu G, Szczepankiewicz BG, Pei Z, Janowick DA, Xin Z, Hajduk PJ, Abad-Zapatero C, Liang H, Hutchins CW, Fesik SW, Ballaron SJ, Stashko MA, Lubben T, Mika AK, Zinker BA, Trevillyan JM, Jirousek MR. Liu G, et al. Among authors: fesik sw. J Med Chem. 2003 May 22;46(11):2093-103. doi: 10.1021/jm0205696. J Med Chem. 2003. PMID: 12747781

2

NMR studies of an FK-506 analog, [U-13C]ascomycin, bound to FK-506-binding protein.

Petros AM, Gemmecker G, Neri P, Olejniczak ET, Nettesheim D, Xu RX, Gubbins EG, Smith H, Fesik SW. Petros AM, et al. Among authors: fesik sw. J Med Chem. 1992 Jun 26;35(13):2467-73. doi: 10.1021/jm00091a015. J Med Chem. 1992. PMID: 1377749

3

NMR studies of molecular complexes as a tool in drug design.

Fesik SW. Fesik SW. J Med Chem. 1991 Oct;34(10):2937-45. doi: 10.1021/jm00114a001. J Med Chem. 1991. PMID: 1920348 Review. No abstract available.

4

Isotope-edited proton NMR study on the structure of a pepsin/inhibitor complex.

Fesik SW, Luly JR, Erickson JW, Abad-Zapatero C. Fesik SW, et al. Biochemistry. 1988 Nov 1;27(22):8297-301. doi: 10.1021/bi00422a001. Biochemistry. 1988. PMID: 3149502

5

Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogues of angiotensinogen.

Sham HL, Bolis G, Stein HH, Fesik SW, Marcotte PA, Plattner JJ, Rempel CA, Greer J. Sham HL, et al. Among authors: fesik sw. J Med Chem. 1988 Feb;31(2):284-95. doi: 10.1021/jm00397a003. J Med Chem. 1988. PMID: 3276890

6

Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol 4,5-bisphosphate.

Harlan JE, Yoon HS, Hajduk PJ, Fesik SW. Harlan JE, et al. Among authors: fesik sw. Biochemistry. 1995 Aug 8;34(31):9859-64. doi: 10.1021/bi00031a006. Biochemistry. 1995. PMID: 7632686

7

Equilibrium denaturation of recombinant human FK binding protein in urea.

Egan DA, Logan TM, Liang H, Matayoshi E, Fesik SW, Holzman TF. Egan DA, et al. Among authors: fesik sw. Biochemistry. 1993 Mar 2;32(8):1920-7. doi: 10.1021/bi00059a006. Biochemistry. 1993. PMID: 7680574

8

Solution structure of a low molecular weight protein tyrosine phosphatase.

Logan TM, Zhou MM, Nettesheim DG, Meadows RP, Van Etten RL, Fesik SW. Logan TM, et al. Among authors: fesik sw. Biochemistry. 1994 Sep 20;33(37):11087-96. doi: 10.1021/bi00203a005. Biochemistry. 1994. PMID: 7727361

9

Solution structure of the ets domain of Fli-1 when bound to DNA.

Liang H, Mao X, Olejniczak ET, Nettesheim DG, Yu L, Meadows RP, Thompson CB, Fesik SW. Liang H, et al. Among authors: fesik sw. Nat Struct Biol. 1994 Dec;1(12):871-5. doi: 10.1038/nsb1294-871. Nat Struct Biol. 1994. PMID: 7773776

10

The secondary structure of the ets domain of human Fli-1 resembles that of the helix-turn-helix DNA-binding motif of the Escherichia coli catabolite gene activator protein.

Liang H, Olejniczak ET, Mao X, Nettesheim DG, Yu L, Thompson CB, Fesik SW. Liang H, et al. Among authors: fesik sw. Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11655-9. doi: 10.1073/pnas.91.24.11655. Proc Natl Acad Sci U S A. 1994. PMID: 7972119 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters